AGL 40.30 Increased By ▲ 0.30 (0.75%)
AIRLINK 127.29 Increased By ▲ 0.25 (0.2%)
BOP 6.67 No Change ▼ 0.00 (0%)
CNERGY 4.49 Decreased By ▼ -0.02 (-0.44%)
DCL 8.64 Increased By ▲ 0.09 (1.05%)
DFML 41.89 Increased By ▲ 0.45 (1.09%)
DGKC 87.90 Increased By ▲ 1.05 (1.21%)
FCCL 32.81 Increased By ▲ 0.53 (1.64%)
FFBL 64.87 Increased By ▲ 0.07 (0.11%)
FFL 10.26 Increased By ▲ 0.01 (0.1%)
HUBC 109.75 Increased By ▲ 0.18 (0.16%)
HUMNL 14.82 Increased By ▲ 0.14 (0.95%)
KEL 5.13 Increased By ▲ 0.08 (1.58%)
KOSM 7.54 Increased By ▲ 0.08 (1.07%)
MLCF 41.84 Increased By ▲ 0.46 (1.11%)
NBP 59.68 Decreased By ▼ -0.73 (-1.21%)
OGDC 194.98 Increased By ▲ 4.88 (2.57%)
PAEL 28.28 Increased By ▲ 0.45 (1.62%)
PIBTL 7.82 Decreased By ▼ -0.01 (-0.13%)
PPL 152.50 Increased By ▲ 2.44 (1.63%)
PRL 26.65 Decreased By ▼ -0.23 (-0.86%)
PTC 16.19 Increased By ▲ 0.12 (0.75%)
SEARL 84.15 Decreased By ▼ -1.85 (-2.15%)
TELE 7.65 Decreased By ▼ -0.06 (-0.78%)
TOMCL 35.45 Increased By ▲ 0.04 (0.11%)
TPLP 8.17 Increased By ▲ 0.05 (0.62%)
TREET 16.17 Decreased By ▼ -0.24 (-1.46%)
TRG 52.80 Decreased By ▼ -0.49 (-0.92%)
UNITY 26.50 Increased By ▲ 0.34 (1.3%)
WTL 1.25 Decreased By ▼ -0.01 (-0.79%)
BR100 9,953 Increased By 69.1 (0.7%)
BR30 30,951 Increased By 351.4 (1.15%)
KSE100 93,912 Increased By 556.1 (0.6%)
KSE30 29,094 Increased By 163.5 (0.57%)

A mother who is the first woman in Britain to have a baby selected free of a gene which causes breast cancer has given birth successfully, doctors said on January 09. "The mother and her little girl are doing very well," said University College London (UCL) of the baby, who grew from an embryo screened to ensure it did not contain the faulty BRCA 1 gene.
The baby's 27-year-old mother, who wants to remain anonymous, decided to take the step because several of her husband's close female relatives suffered from breast cancer.
Any daughter born with the BRCA 1 gene has an 80 per cent risk of developing breast cancer and a 60 per cent chance of developing ovarian cancer - as well as a 50 percent risk of passing on the anomaly to their own children. Doctors said the parents were relieved to have a guarantee that the faulty gene would not be passed to their daughter.
"This little girl will not face the spectre of developing this genetic form of breast cancer or ovarian cancer in her adult life," said Paul Serhal, head of the Assisted Conception Unit at UCL Hospital. The procedure was carried out using a technique known as pre-implantation genetic diagnosis which has already been used here to screen embryos resulting from in vitro fertilisation for disorders like cystic fibrosis.
It was given the green light in Britain in 2006. The procedure is still relatively rare but has been used to screen embryos for breast cancer in the United States and Belgium.

Copyright Agence France-Presse, 2009

Comments

Comments are closed.